Description
Global Minimally Invasive Spine Technologies Market Industry Overview
The global minimally invasive spine technologies market was valued at $3,180.9 million in 2022 and is anticipated to reach $9,406.5 million by 2032, witnessing a CAGR of 11.45% during the forecast period 2022-2032. The growth in the global minimally invasive spine technologies market is expected to be driven by the rising preference for minimally invasive spine surgical procedures globally and increasing awareness among practitioners for simulation, training, and continuous medical education.
Market Lifecycle Stage
The minimally invasive spine technologies market is in the developing phase. The rising demand for minimally invasive surgeries and robotic-assisted surgeries and increasing synergetic activities within the spine surgery industry are some of the major opportunities in the global minimally invasive spine technologies market. Furthermore, some of the key trends going on in the market are the technological advancements in the field of medical surgery, such as the incorporation of AI, the shift of procedures to ambulatory surgery centers, and increasing synergistic activities.
Impact of COVID-19
The demand for minimally invasive spine technologies witnessed a decline during the pandemic owing to postponing of elective surgeries and other non-urgent procedures. Most of the spinal surgeons’ work was eliminated with the closure of elective surgery and outpatient clinics. It was crucial that emergency spinal care was provided throughout the pandemic, including the development of guidelines to help spinal surgeons properly handle patients.
Furthermore, lockdowns and travel restrictions during the pandemic caused delays in the procurement of raw materials as well as delivery to end users.
Market Segmentation:
Segmentation 1: by Condition
• Herniated Disc
• Spinal Stenosis
• Degenerative Disc Disease
• Spinal Deformity
• Spinal Fracture
• Spinal Infection
• Spinal Tumor
The global minimally invasive spine technologies market in the Condition type segment is expected to be dominated by the degenerative disc disease segment.
Segmentation 2: by End User
• Hospitals
• Ambulatory Surgery Centers
• Orthopedic Clinics
The global minimally invasive spine technologies market in the end user segment is expected to be dominated by the hospitals segment.
Segmentation 3: by Region
• North America – U.S. and Canada
• Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Middle East and Africa – South Africa, U.A.E, and Rest-of-Middle East and Africa
Recent Developments in the Global Minimally Invasive Spine Technologies Market
• In June 2022, NuVasive, Inc. opened its Singapore Experience Center for the Asia-Pacific region to support the company’s growth and increase its global footprint.
• In April 2022, SeaSpine launched the Reef TA (TLIF Articulating) Interbody System. This new system is engineered to deliver an interbody to the front part of the spinal disc space with precision, with the aim of enhancing sagittal alignment and endplate support. The Reef TA Interbody System offers a variety of footprint and lordotic options, giving surgeons the flexibility to address specific anatomical requirements during the surgical procedure.
• In October 2022, Orthofix and SeaSpine merged as equals to form a leading global company in the spine and orthopedics industry.
• In July 2022, Medtronic plc received approval from the U.S. Food and Drug Administration (FDA) for its latest version of the UNiD Spine Analyzer, which includes a predictive model for degenerative spinal surgery.
• In October 2022, Captiva Spine entered into an exclusive strategic partnership with REMEX Medical for Spine Navigation and Robotics for the expansion of their product portfolio.
Demand – Drivers and Limitations
The following are the drivers for the minimally invasive spine technologies market:
• Increasing Incidences and Prevalence of Spinal Disorders
• Increasing Preference for Minimally Invasive Spine Surgeries
• Technological Advancement in Minimally Invasive Spine Surgical Procedures
The market is expected to face some limitations due to the following challenges:
• Lack of Well-Established Landscape for Reimbursement for Minimally Invasive Spinal Procedures
• High Cost of Capital Equipment Purchases and Disposables
• Lack of Training Leading to Shortage of Skilled Professionals
How can this report add value to an organization?
Product/Innovation Strategy: The condition segment helps the reader understand the different types of diseases and their effective treatment using minimally invasive spine surgical techniques available for use in the minimally invasive spine technologies industry. Moreover, the study gives the reader an insight into different applications and robotic-assisted surgeries by end users (hospitals, ambulatory surgery centers, and orthopedic clinics).
Growth/Marketing Strategy: The global minimally invasive spine technologies market has seen major developments by key players operating in the market, such as partnerships, collaborations and business expansions, mergers and acquisitions, product launches, and funding activities. The favored strategy for the companies has been new offerings in the minimally invasive spine technologies market. For instance, in November 2022, Nuvasive, Inc. launched the NuVasive Tube System (NTS) and the Excavation Micro, an innovative minimally invasive surgical system that offers complete solutions for both transforaminal lumbar interbody fusion (TLIF) and decompression procedures. These new products expand the company’s range of access and instrumentation technology offerings as part of the NuVasive P360 portfolio.
Competitive Strategy: Key players in the global minimally invasive spine technologies market analyzed and profiled in the study involve players that offer surgical systems, instruments, and systems. Moreover, a detailed market share analysis of the players operating in the global minimally invasive spine technologies market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Key Companies Profiled
• AMS Group
• Alphatec Holdings, Inc.
• Aurora Spine, Inc.
• B. Braun SE
• Boston Scientific Corporation
• Globus Medical, Inc.
• Johnson & Johnson
• Medtronic plc
• NuVasive, Inc.
• ORTHOFIX MEDICAL INC.
• Precision Spine, Inc.
• Richard Wolf GmbH
• Spineart
• Spineology Inc.
• Stryker Corporation
Table of Contents
1 Markets
1.1 Global Market Outlook
1.1.1 Market Overview
1.1.2 Product Definition
1.1.3 Inclusion and Exclusion Criteria
1.1.4 Key Findings
1.1.5 Assumptions and Limitations
1.1.6 Market Growth Scenario
1.1.6.1 Realistic Growth Scenario
1.1.6.2 Optimistic Growth Scenario
1.1.6.3 Pessimistic Growth Scenario
1.2 Industry Outlook
1.2.1 Key Trends
1.2.2 Opportunity Assessment
1.2.3 Patent Analysis
1.2.3.1 Awaited Technological Developments
1.2.3.2 Patent Filing Trend (by Country)
1.2.3.3 Patent Filing Trend (by Year)
1.2.4 Product Benchmarking
1.2.5 Clinical Trials
1.3 Impact of COVID-19 on the Global Minimally Invasive Spine Technologies
1.3.1 Pre-COVID-19 Phase
1.3.2 During COVID-19
1.3.3 Post-COVID-19 Phase
1.3.3.1 Impact on Demand and Supply
1.3.3.2 Impact on Competitive Landscape
1.3.3.3 Impact on Company Revenue
1.4 Business Dynamics
1.4.1 Impact Analysis
1.4.2 Business Drivers
1.4.2.1 Increasing Incidences and Prevalence of Spinal Disorders
1.4.2.2 Increasing Preference for Minimally Invasive Spine Surgeries
1.4.2.3 Technological Advancement in Minimally Invasive Spine Surgical Procedures
1.4.3 Business Restraints
1.4.3.1 Lack of Well-Established Landscape for Reimbursement for Minimally Invasive Spinal Procedures
1.4.3.2 Factors Hindering the Implementation of Minimally Invasive Spinal Surgeries
1.4.3.2.1 High Cost of Capital Equipment Purchases and Disposables
1.4.3.2.2 Lack of Training Leading to Shortage of Skilled Professionals
1.4.4 Business Opportunities
1.4.4.1 Augmentation of Artificial Intelligence in Minimally Invasive Spine Surgery
1.4.4.2 Leveraging Synergies to Diversify Business Portfolio
2 Global Minimally Invasive Spine Technologies Market (by Condition)
2.1 Overview
2.2 Opportunity Assessment
2.3 Herniated Disc
2.4 Spinal Stenosis
2.5 Degenerative Disc Disease
2.6 Spinal Deformity
2.7 Spinal Fracture
2.8 Spinal Infection
2.9 Spinal Tumor
3 Global Minimally Invasive Spine Technologies Market (by End User)
3.1 Overview
3.2 Opportunity Assessment
3.3 Hospitals
3.4 Ambulatory Surgery Centers
3.5 Orthopedic Clinics
4 Global Minimally Invasive Spine Technologies Market (by Region)
4.1 North America Minimally Invasive Spine Technologies Market
4.1.1 Regulatory Framework
4.1.2 Key Findings and Opportunity Assessment
4.1.3 Market Dynamics
4.1.3.1 Impact Analysis
4.1.4 Market Sizing and Forecast
4.1.4.1 North America Minimally Invasive Spine Technologies Market (by Country)
4.1.4.1.1 U.S.
4.1.4.1.1.1 Market Dynamics
4.1.4.1.1.2 Market Size and Forecast
4.1.4.1.2 Canada
4.1.4.1.2.1 Market Dynamics
4.1.4.1.2.2 Market Size and Forecast
4.2 Europe Minimally Invasive Spine Technologies Market
4.2.1 Regulatory Framework
4.2.1.1 Spinal Classification EU MDR Model Proposed by Team NB
4.2.2 Key Findings and Opportunity Assessment
4.2.3 Market Dynamics
4.2.3.1 Impact Analysis
4.2.4 Market Sizing and Forecast
4.2.4.1 Europe Minimally Invasive Spine Technologies Market (by Country)
4.2.4.1.1 Germany
4.2.4.1.1.1 Market Dynamics
4.2.4.1.1.2 Market Size and Forecast
4.2.4.1.2 U.K.
4.2.4.1.2.1 Market Dynamics
4.2.4.1.2.2 Market Size and Forecast
4.2.4.1.3 France
4.2.4.1.3.1 Market Dynamics
4.2.4.1.3.2 Market Size and Forecast
4.2.4.1.4 Italy
4.2.4.1.4.1 Market Dynamics
4.2.4.1.4.2 Market Size and Forecast
4.2.4.1.5 Spain
4.2.4.1.5.1 Market Dynamics
4.2.4.1.5.2 Market Size and Forecast
4.2.4.1.6 Rest-of-Europe
4.2.4.1.6.1 Market Dynamics
4.2.4.1.6.2 Market Size and Forecast
4.3 Asia-Pacific
4.3.1 Regulatory Framework
4.3.2 Key Findings and Opportunity Assessment
4.3.3 Market Dynamics
4.3.3.1 Impact Analysis
4.3.4 Market Sizing and Forecast Analysis
4.3.4.1 Asia-Pacific Minimally Invasive Spine Technologies Market (by Country)
4.3.4.1.1 Japan
4.3.4.1.1.1 Market Dynamics
4.3.4.1.1.2 Market Size and Forecast
4.3.4.1.2 China
4.3.4.1.2.1 Market Dynamics
4.3.4.1.2.2 Market Size and Forecast
4.3.4.1.3 Australia
4.3.4.1.3.1 Market Dynamics
4.3.4.1.3.2 Market Size and Forecast
4.3.4.1.4 India
4.3.4.1.4.1 Market Dynamics
4.3.4.1.4.2 Market Size and Forecast
4.3.4.1.5 South Korea
4.3.4.1.5.1 Market Dynamics
4.3.4.1.5.2 Market Size and Forecast
4.3.4.1.6 Rest-of-Asia-Pacific
4.3.4.1.6.1 Market Dynamics
4.3.4.1.6.2 Market Size and Forecast
4.4 Latin America
4.4.1 Regulatory Framework
4.4.2 Key Findings and Opportunity Assessment
4.4.3 Market Dynamics
4.4.3.1 Impact Analysis
4.4.4 Market Sizing and Forecast Analysis
4.4.4.1 Latin America Minimally Invasive Spine Technologies Market (by Country)
4.4.4.1.1 Brazil
4.4.4.1.1.1 Market Dynamics
4.4.4.1.1.2 Market Size and Forecast
4.4.4.1.2 Mexico
4.4.4.1.2.1 Market Dynamics
4.4.4.1.2.2 Market Size and Forecast
4.4.4.1.3 Rest-of-Latin America
4.4.4.1.3.1 Market Dynamics
4.4.4.1.3.2 Market Size and Forecast
4.5 Middle East and Africa
4.5.1 Regulatory Framework
4.5.2 Key Findings and Opportunity Assessment
4.5.3 Market Dynamics
4.5.3.1 Impact Analysis
4.5.4 Market Sizing and Forecast Analysis
4.5.4.1 Middle East and Africa Minimally Invasive Spine Technologies Market (by Country)
4.5.4.1.1 South Africa
4.5.4.1.1.1 Market Dynamics
4.5.4.1.1.2 Market Size and Forecast
4.5.4.1.2 U.A.E
4.5.4.1.2.1 Market Dynamics
4.5.4.1.2.2 Market Size and Forecast
4.5.4.1.3 Rest-of-Middle East and Africa
4.5.4.1.3.1 Market Dynamics
4.5.4.1.3.2 Market Size and Forecast
5 Competitive Benchmarking and Company Profiles
5.1 Competitive Landscape
5.1.1 Key Strategies and Developments
5.1.1.1 Regulatory and Legal Activities
5.1.1.2 New Offerings
5.1.1.3 Mergers and Acquisitions
5.1.1.4 Partnerships, Collaborations, and Business Expansions
5.2 Company Profiles
5.2.1 AMS Group
5.2.1.1 Company Overview
5.2.1.2 Role of AMS Group in the Global Minimally Invasive Spine Technologies Market
5.2.1.3 Analyst Perspective
5.2.2 Alphatec Holdings, Inc.
5.2.2.1 Company Overview
5.2.2.2 Role of Alphatec Holdings, Inc. in the Global Minimally Invasive Spine Technologies Market
5.2.2.3 Financials
5.2.2.4 Recent Developments
5.2.2.5 Analyst Perspective
5.2.3 Aurora Spine, Inc.
5.2.3.1 Company Overview
5.2.3.2 Role of Aurora Spine, Inc. in the Global Minimally Invasive Spine Technologies Market
5.2.3.3 Recent Developments
5.2.3.4 Analyst Perspective
5.2.4 B. Braun SE
5.2.4.1 Company Overview
5.2.4.2 Role of B. Braun SE in the Global Minimally Invasive Spine Technologies Market
5.2.4.3 Product Portfolio
5.2.4.4 Financials
5.2.4.5 Analyst Perception
5.2.5 Boston Scientific Corporation
5.2.5.1 Company Overview
5.2.5.2 Role of Boston Scientific Corporation in the Minimally Invasive Spine Technologies Market
5.2.5.3 Product Portfolio
5.2.5.4 Financials
5.2.5.5 Analyst Perception
5.2.6 Globus Medical, Inc.
5.2.6.1 Company Overview
5.2.6.2 Role of Globus Medical, Inc. in the Global Minimally Invasive Spine Technologies Market
5.2.6.3 Financials
5.2.6.4 Analyst Perspective
5.2.7 Johnson & Johnson
5.2.7.1 Company Overview
5.2.7.2 Role of Johnson & Johnson in the Global Minimally Invasive Spine Technologies Market
5.2.7.3 Product Portfolio
5.2.7.4 Financials
5.2.7.5 Recent Developments
5.2.7.6 Analyst Perception
5.2.8 Medtronic plc
5.2.8.1 Company Overview
5.2.8.2 Role of Medtronic plc in the Global Minimally Invasive Spine Technologies Market
5.2.8.3 Product Portfolio
5.2.8.4 Financials
5.2.8.5 Recent Developments
5.2.8.6 Analyst Perception
5.2.9 NuVasive, Inc.
5.2.9.1 Company Overview
5.2.9.2 Role of NuVasive, Inc. in the Global Minimally Invasive Spine Technologies Market
5.2.9.3 Financials
5.2.9.4 Recent Developments
5.2.9.5 Analyst Perspective
5.2.10 ORTHOFIX MEDICAL INC.
5.2.10.1 Company Overview
5.2.10.2 Role of ORTHOFIX MEDICAL INC. in the Global Minimally Invasive Spine Technologies Market
5.2.10.3 Financials
5.2.10.4 Analyst Perspective
5.2.11 Precision Spine, Inc.
5.2.11.1 Company Overview
5.2.11.2 Role of Precision Spine, Inc. in the Global Minimally Invasive Spine Technologies Market
5.2.11.3 Recent Developments
5.2.11.4 Analyst Perspective
5.2.12 Richard Wolf GmbH
5.2.12.1 Company Overview
5.2.12.2 Role of Richard Wolf GmbH in the Global Minimally Invasive Spine Technologies Market
5.2.12.3 Analyst Perspective
5.2.13 Spineart
5.2.13.1 Company Overview
5.2.13.2 Role of Spineart in the Global Minimally Invasive Spine Technologies Market
5.2.13.3 Recent Developments
5.2.13.4 Analyst Perspective
5.2.14 Spineology Inc.
5.2.14.1 Company Overview
5.2.14.2 Role of Spineology Inc. in the Global Minimally Invasive Spine Technologies Market
5.2.14.3 Recent Developments
5.2.14.4 Analyst Perspective
5.2.15 Stryker Corporation
5.2.15.1 Company Overview
5.2.15.2 Role of Stryker Corporation in the Global Minimally Invasive Spine Technologies Market
5.2.15.3 Financials
5.2.15.4 Recent Developments
5.2.15.5 Analyst Perspective
List of Figures
Figure 1: Minimally Invasive Spine Surgery Techniques
Figure 2: Global Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 3: Global Minimally Invasive Spine Technologies Market (by Condition), $Million, 2021 and 2032
Figure 4: Global Minimally Invasive Spine Technologies Market (by Region), $Million, 2022 and 2032
Figure 5: Global Minimally Invasive Spine Technologies Market, Market Dynamics
Figure 6: Global Minimally Invasive Spine Technologies Segmentation
Figure 7: Global Minimally Invasive Spine Technologies Market: Research Methodology
Figure 8: Primary Research
Figure 9: Secondary Research
Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
Figure 11: Top-Down Approach (Segment-Wise Analysis)
Figure 12: Assumptions and Limitations
Figure 13: Global Minimally Invasive Spine Technologies Market Size and Growth Potential (Realistic Growth Scenario), $Million, 2021-2032
Figure 14: Global Minimally Invasive Spine Technologies Market Size and Growth Potential (Optimistic Scenario), $Million, 2021-2032
Figure 15: Global Minimally Invasive Spine Technologies Market Size and Growth Potential (Pessimistic Scenario), $Million, 2021-2032
Figure 16: Global Minimally Invasive Spine Technologies Market, Key Trends
Figure 17: Global Minimally Invasive Spine Technologies Market, Key Trends, Market Shift, 2022-2032
Figure 18: Global Minimally Invasive Spine Technologies Market, Patent Analysis (by Country), January 2018-January 2023
Figure 19: Global Minimally Invasive Spine Technologies Market, Patent Analysis (by Year), January 2018-January 2023
Figure 20: Global Minimally Invasive Spine Technologies Market, Impact Analysis
Figure 21: Incidence of Degenerative Spine Disease, by Region, 2018
Figure 22: Geriatric Population Growth, by Region, 2019 vs. 2050
Figure 23: Prevalence of Spinal Degeneration (by Age), 2021
Figure 24: Next-Generation Products for Minimally Invasive Spine Surgery
Figure 25: Relative Comparison of Operative Factors in 2-Dimensional Versus 3-Dimensional Minimally Invasive Spine Surgery
Figure 26: Cost of Robotic-Assisted Systems Used in Spine Surgery
Figure 27: Artificial Intelligence Improving the Quality and Delivery of Care
Figure 28: Global Minimally Invasive Spine Technologies Market (by Condition)
Figure 29: Global Minimally Invasive Spine Technologies Market, Incremental Opportunity (by Condition), $Million, 2021-2032
Figure 30: Global Minimally Invasive Spine Technologies Market (Herniated Disc), $Million, 2021-2032
Figure 31: Global Minimally Invasive Spine Technologies Market (Spinal Stenosis), $Million, 2021-2032
Figure 32: Global Minimally Invasive Spine Technologies Market (Degenerative Disc Disease), $Million, 2021-2032
Figure 33: Global Minimally Invasive Spine Technologies Market (Spinal Deformity), $Million, 2021-2032
Figure 34: Global Minimally Invasive Spine Technologies Market (Spinal Fracture), $Million, 2021-2032
Figure 35: Global Minimally Invasive Spine Technologies Market (Spinal Infection), $Million, 2021-2032
Figure 36: Global Minimally Invasive Spine Technologies Market (Spinal Tumor), $Million, 2021-2032
Figure 37: Global Minimally Invasive Spine Technologies Market (by End User)
Figure 38: Global Minimally Invasive Spine Technologies Market Incremental Opportunity (by End User), $Million, 2021-2032
Figure 39: Global Minimally Invasive Spine Technologies Market (Hospitals), $Million, 2021-2032
Figure 40: Global Minimally Invasive Spine Technologies Market (Ambulatory Surgery Centers), $Million, 2021-2032
Figure 41: Global Minimally Invasive Spine Technologies Market (Orthopedic Clinics), $Million, 2021-2032
Figure 42: Global Minimally Invasive Spine Technologies Market Share (by Region), 2021 and 2032
Figure 43: North America Minimally Invasive Spine Technologies Market Incremental Opportunity (by Country), $Million, 2021-2032
Figure 44: North America Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 45: North America Minimally Invasive Spine Technologies Market (by Country), Share (%), 2021 and 2032
Figure 46: U.S. Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 47: Canada Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 48: Europe Minimally Invasive Spine Technologies Market Incremental Opportunity (by Country), $Million, 2021-2032
Figure 49: Europe Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 50: Europe Minimally Invasive Spine Technologies Market (by Country), Share (%), 2021 and 2032
Figure 51: Germany Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 52: U.K. Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 53: France Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 54: Italy Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 55: Spain Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 56: Rest-of-Europe Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 57: Asia-Pacific Minimally Invasive Spine Technologies Market Incremental Opportunity (by Country), $Million, 2021-2032
Figure 58: Asia-Pacific Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 59: Asia-Pacific Minimally Invasive Spine Technologies Market (by Country), % Share, 2021 and 2032
Figure 60: Japan Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 61: China Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 62: Australia Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 63: India Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 64: South Korea Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 65: Rest-of-Asia-Pacific Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 66: Latin America Minimally Invasive Spine Technologies Market Incremental Opportunity (by Country), $Million, 2021-2032
Figure 67: Latin America Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 68: Latin America Minimally Invasive Spine Technologies Market (by Country), % Share, 2021 and 2032
Figure 69: Brazil Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 70: Mexico Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 71: Rest-of-Latin America Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 72: Middle East and Africa Minimally Invasive Spine Technologies Market Incremental Opportunity (by Country), $Million, 2021-2032
Figure 73: Middle East and Africa Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 74: Middle East and Africa Minimally Invasive Spine Technologies Market (by Country), % Share, 2021 and 2032
Figure 75: South Africa Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 76: U.A.E Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 77: Rest-of-Middle East and Africa Minimally Invasive Spine Technologies Market, $Million, 2021-2032
Figure 78: Share of Key Developments and Strategies, January 2018-January 2023
Figure 79: Regulatory and Legal Activities, January 2018-January 2023
Figure 80: New Offerings, January 2018-January 2023
Figure 81: Mergers and Acquisitions, January 2018-January 2023
Figure 82: Partnerships, Alliances, and Business Expansions, January 2018-January 2023
Figure 83: AMS Group: Overall Product Portfolio
Figure 84: Alphatec Holdings, Inc.: Product Portfolio
Figure 85: Alphatec Holdings, Inc.: Overall Financials, $Million, 2019-2021
Figure 86: Alphatec Holdings, Inc.: Revenue (by Region), $Million, 2020-2021
Figure 87: Alphatec Holdings, Inc.: R&D Expense, $Million, 2019-2021
Figure 88: Aurora Spine, Inc.: Overall Product Portfolio
Figure 89: B. Braun SE: Overall Product Portfolio
Figure 90: B. Braun SE: Overall Financials, $Million, 2019-2021
Figure 91: B. Braun SE: Revenue (by Segment), $Million, 2019-2021
Figure 92: B. Braun SE: Revenue (by Region), $Million, 2019-2021
Figure 93: B. Braun SE: R&D Expense, $Million, 2019-2021
Figure 94: Boston Scientific Corporation: Overall Product Portfolio
Figure 95: Boston Scientific Corporation: Overall Financials, $Million, 2019-2021
Figure 96: Boston Scientific Corporation: Revenue (by Segment), $Million, 2019-2021
Figure 97: Boston Scientific Corporation: R&D Expense, $Million, 2019-2021
Figure 98: Globus Medical, Inc.: Overall Product Portfolio
Figure 99: Globus Medical, Inc.: Overall Financials ($Million), 2019-2021
Figure 100: Globus Medical, Inc.: Net Revenue (by Region), $Million, 2019-2021
Figure 101: Johnson & Johnson: Overall Product Portfolio
Figure 102: Johnson & Johnson: Overall Financials, $Million, 2019-2021
Figure 103: Johnson & Johnson: Revenue (by Segment), $Million, 2019-2021
Figure 104: Johnson & Johnson: Revenue (by Region), $Million 2019-2021
Figure 105: Johnson & Johnson: R&D Expense, $Million, 2019-2021
Figure 106: Medtronic plc: Overall Product Portfolio
Figure 107: Medtronic plc: Overall Financials, $Million, 2020-2022
Figure 108: Medtronic plc: Revenue (by Segment), $Million, 2020-2022
Figure 109: Medtronic plc: Revenue (by Region), $Million, 2020-2022
Figure 110: Medtronic plc: R&D Expense, $Million, 2020-2022
Figure 111: NuVasive, Inc.: Product Portfolio
Figure 112: NuVasive, Inc.: Overall Financials, $Million, 2019-2021
Figure 113: NuVasive, Inc.: Revenue (by Business Segment), $Million, 2019-2021
Figure 114: NuVasive, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 115: NuVasive, Inc.: R&D Expense, $Million, 2019-2021
Figure 116: ORTHOFIX MEDICAL INC.: Product Portfolio
Figure 117: ORTHOFIX MEDICAL INC.: Overall Financials, $Million, 2019-2021
Figure 118: ORTHOFIX MEDICAL INC.: Revenue (by Business Segment), $Million, 2019-2021
Figure 119: ORTHOFIX MEDICAL INC.: Revenue (by Region), $Million, 2019-2021
Figure 120: ORTHOFIX MEDICAL INC.: R&D Expense, $Million, 2019-2021
Figure 121: Precision Spine, Inc.: Overall Product Portfolio
Figure 122: Richard Wolf GmbH.: Overall Product Portfolio
Figure 123: Spineart: Overall Product Portfolio
Figure 124: Spineology Inc.: Overall Product Portfolio
Figure 125: Stryker Corporation: Product Portfolio
Figure 126: Stryker Corporation: Overall Financials, $Million, 2019-2021
Figure 127: Stryker Corporation: Revenue (by Business Segment), $Million, 2019-2021
Figure 128: Stryker Corporation: Revenue (by Region), $Million, 2019-2021
Figure 129: Stryker Corporation: R&D Expense, $Million, 2019-2021
List of Tables
Table 1: Key Challenges and Possible Solutions for Players in the Global Minimally Invasive Spine Technologies Market
Table 2: Global Minimally Invasive Spine Technologies Market, Quarterly Key Developments Analysis, January 2018-January 2023
Table 3: Key Questions Answered in the Report
Table 4: Parameters for Realistic, Optimistic, and Pessimistic Growth Scenarios
Table 5: Global Minimally Invasive Spine Technologies Market, Awaited Technologies
Table 6: Global Minimally Invasive Spine Technologies Market, Product Benchmarking
Table 7: Global Minimally Invasive Spine Technologies Market, Ongoing Clinical Trials
Table 8: North America Minimally Invasive Spine Technologies Market, Regulatory Framework
Table 9: North America Minimally Invasive Spine Technologies Market, Impact Analysis
Table 10: Europe Minimally Invasive Spine Technologies Market, Impact Analysis
Table 11: Asia-Pacific Minimally Invasive Spine Technologies Market, Regulatory Framework
Table 12: Asia-Pacific Minimally Invasive Spine Technologies Market, Impact Analysis
Table 13: Latin America Minimally Invasive Spine Technologies Market, Regulatory Framework
Table 14: Latin America Minimally Invasive Spine Technologies Market, Impact Analysis
Table 15: Middle East and Africa Minimally Invasive Spine Technologies Market, Regulatory Framework
Table 16: Middle East and Africa Minimally Invasive Spine Technologies Market, Impact Analysis
Table 17: AMS Group: Key Products and Features
Table 18: Alphatec Holdings, Inc.: Key Product Specification
Table 19: Aurora Spine, Inc.: Key Products and Features
Table 20: B. Braun SE: Key Products and Features
Table 21: Boston Scientific Corporation: Key Products and Features
Table 22: Globus Medical, Inc.: Key Products and Features
Table 23: Johnson & Johnson: Key Products and Features
Table 24: Medtronic plc: Key Products and Features
Table 25: NuVasive, Inc.: Key Product Specification
Table 26: ORTHOFIX MEDICAL INC., Key Product Specification
Table 27: Precision Spine, Inc.: Key Products and Features
Table 28: RIWOspine GmbH.: Key Products and Features
Table 29: Spineart: Key Products and Features
Table 30: Spineology Inc.: Key Products and Features
Table 31: Stryker Corporation, Key Product Specification
Reviews
There are no reviews yet.